Recent Finacing
Recent Raise
Ambrx is a San Diego-based clinical-stage biopharmaceutical company using an expanded genetic code for site-specific protein conjugation to develop ADCs, bispecifics, targeted immuno-oncology therapies, novel cytokines, and long-acting peptides.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
